- Home
- GH vs ENIC Comparison
GH vs ENIC Comparison
Compare GH & ENIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- ENIC
- Stock Information
- Founded
- GH 2011
- ENIC 2016
- Country
- GH United States
- ENIC Chile
- Employees
- GH N/A
- ENIC N/A
- Industry
- GH Medical Specialities
- ENIC Electric Utilities: Central
- Sector
- GH Health Care
- ENIC Utilities
- Exchange
- GH Nasdaq
- ENIC Nasdaq
- Market Cap
- GH 4.9B
- ENIC 4.8B
- IPO Year
- GH 2018
- ENIC N/A
- Fundamental
- Price
- GH $49.14
- ENIC $3.53
- Analyst Decision
- GH Strong Buy
- ENIC Hold
- Analyst Count
- GH 20
- ENIC 1
- Target Price
- GH $54.35
- ENIC $3.90
- AVG Volume (30 Days)
- GH 2.2M
- ENIC 1.6M
- Earning Date
- GH 08-06-2025
- ENIC 07-23-2025
- Dividend Yield
- GH N/A
- ENIC 1.34%
- EPS Growth
- GH N/A
- ENIC N/A
- EPS
- GH N/A
- ENIC 0.00
- Revenue
- GH $773,996,000.00
- ENIC $4,104,736,933.00
- Revenue This Year
- GH $23.14
- ENIC $112,481.17
- Revenue Next Year
- GH $21.42
- ENIC $1.87
- P/E Ratio
- GH N/A
- ENIC $29.34
- Revenue Growth
- GH 28.20
- ENIC N/A
- 52 Week Low
- GH $20.14
- ENIC $2.51
- 52 Week High
- GH $52.92
- ENIC $4.05
- Technical
- Relative Strength Index (RSI)
- GH 62.17
- ENIC 43.04
- Support Level
- GH $48.00
- ENIC $3.58
- Resistance Level
- GH $51.71
- ENIC $3.71
- Average True Range (ATR)
- GH 2.67
- ENIC 0.08
- MACD
- GH 0.39
- ENIC -0.01
- Stochastic Oscillator
- GH 78.60
- ENIC 21.83
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About ENIC Enel Chile S.A. (Each representing 50 shares of)
Enel Chile SA is an electricity utility company, which through its subsidiaries and affiliates is engaged in the generation, transmission and distribution of electricity businesses in Chile. It operates through two segments including Generation Business and Distribution and Network Business. The Generation Business Segment is comprised of a group of electricity companies that own electricity generating plants, whose energy is transmitted and distributed to end customers. The Distribution and Network Reportable Segment is comprised of a group of electricity companies operating under a public utility concession.